Preparing for unannounced medical device inspections in the EU - are you ready?
This article was originally published in SRA
Executive Summary
Unannounced visits from notified bodies are going to be part of life for medical device manufacturers in the EU. Inspectors arriving unannounced will expect a manufacturer to free up staff to host the visit and make available testing equipment dedicated for their immediate use. There will also be cost implications for device makers. Gert Bos and Françoise Schlemmer explain why it is critical that manufacturers and subcontractors practise and validate protocols for hosting such visits.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.